Disease: Pheochromocytoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0031511
Disease: Pheochromocytoma
Pheochromocytoma 		0.060 Biomarker disease BEFREE Bilateral Adrenal Extremely Intense Metabolic Activity on 18F-FDG PET/CT in a Patient With Pheochromocytomas. 31107752 2019
CUI: C0031511
Disease: Pheochromocytoma
Pheochromocytoma 		0.060 AlteredExpression disease BEFREE AP = arterial phase; CECT = contrast-enhanced computed tomography; CT = computed tomography; DP = delayed phase; EVP = early venous phase; FDG = fluorodeoxyglucose; fPFMN = fractionated plasma free metanephrine; HU = Hounsfield units; MIBG = metaiodobenzylguanidine; MRI = magnetic resonance imaging; OOZ = organ of Zuckerkandl; PAE = percentage arterial enhancement; PCC = pheochromocytoma; PET = positron emission tomography; PFNMN = plasma free normetanephrine; PGL = paraganglioma; PRRT = peptide receptor radionuclide therapy; PVE = percentage venous enhancement; sPGL = sympathetic paraganglioma; UP = unenhanced phase; VMA = vanillyl mandelic acid. 30913014 2019
CUI: C0031511
Disease: Pheochromocytoma
Pheochromocytoma 		0.060 Biomarker disease BEFREE Static single-time-frame <sup>18</sup>F-FDG PET/CT is useful for the localization and functional characterization of pheochromocytomas and paragangliomas (PPGLs). 30413658 2019
CUI: C0031511
Disease: Pheochromocytoma
Pheochromocytoma 		0.060 Biomarker disease BEFREE Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery. 29334561 2019
CUI: C0031511
Disease: Pheochromocytoma
Pheochromocytoma 		0.060 Biomarker disease BEFREE 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma. 31306205 2019
CUI: C0031511
Disease: Pheochromocytoma
Pheochromocytoma 		0.060 Biomarker disease BEFREE A 37-year-old woman with pheochromocytoma underwent presurgical FDG PET/CT. 29916915 2018